Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

Labcorp Holdings Inc. LH, or Labcorp, is well-poised for growth in the coming quarters owing to its progress on its strategic priority to lead in important specialty testing areas, which are growth ...

Labcorp currently trades at $265.08 per share and has shown little upside over the past six months, posting a middling return ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Collaboration leverages Olaris' scientific leadership in transplant diagnostics and Labcorp's scientific expertise and national scale to advance post-transplant monitoring. FRAMINGHAM, Mass.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide ...

The Directorate of Education (DoE), Delhi, has declared the Delhi CM SHRI School admission test result 2026 for Class 11 students on May 31. Candidates who appeared for the entrance examination can ...

As healthcare becomes increasingly consumer-driven, individuals are turning to AI tools to help interpret health information, from understanding lab results to determining next steps in care.

Traditionally, physicians ordered tests by faxing paper orders and received results as PDFs. The processes were initially digitized on a lab-by-lab basis. Epic developed Aura to eliminate the need for ...